Back to Search
Start Over
Neuroendocrinological treatment targets for posttraumatic stress disorder
- Source :
- Progress in Neuro-Psychopharmacology and Biological Psychiatry. 90:212-222
- Publication Year :
- 2019
- Publisher :
- Elsevier BV, 2019.
-
Abstract
- Posttraumatic stress disorder (PTSD) is prevalent, disabling, and frequently becomes chronic. Despite this, only two selective serotonergic reuptake inhibitors have been approved to date for its treatment by the United States Food and Drug Administration, and treatment results are often disappointing, with a remission rate of
- Subjects :
- Serotonergic
behavioral disciplines and activities
Stress Disorders, Post-Traumatic
03 medical and health sciences
chemistry.chemical_compound
0302 clinical medicine
mental disorders
medicine
Animals
Humans
Biological Psychiatry
Hydrocortisone
Pharmacology
Psychotropic Drugs
business.industry
Allopregnanolone
Extinction (psychology)
Neurosecretory Systems
030227 psychiatry
Posttraumatic stress
chemistry
Memory consolidation
Reuptake inhibitor
business
medicine.drug
Clinical psychology
Cognitive appraisal
Subjects
Details
- ISSN :
- 02785846
- Volume :
- 90
- Database :
- OpenAIRE
- Journal :
- Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Accession number :
- edsair.doi.dedup.....b8603f1c865056d515c86712cb1dbd3b